系统性红斑狼疮关节炎亚型的特征:患病率、临床特征及I型干扰素特征的作用
该观察性队列研究纳入2264例SLE患者,55.1%有关节炎,其中非变形性关节炎(NDA)占72.8%、Jaccoud关节病(JA)占19.2%、临床不可复位畸形关节炎(CIDA)占8.1%。多变量分析显示JA与更长病程和女性相关,CIDA与神经受累、抗Ro抗体、更高调整平均关节计数和更低调整平均SLEDAI-2K相关;在475例有IFN评分者中,CIDA与低IFN特征相关,而JA和NDA与高IFN特征相关。
要点
- SLE关节炎以NDA最常见(72.8%),JA占19.2%,CIDA占8.1%。
- JA与更长病程(OR 1.05)和女性(OR 2.06)独立相关。
- CIDA与神经受累、抗Ro抗体、更高关节计数和更低SLEDAI-2K相关。
核心结论
- JA和CIDA具有不同的临床和血清学模式,提示SLE变形性关节炎存在独特机制。
- NDA和JA均表现为高I型干扰素特征,而CIDA表现为较低干扰素特征和更高关节负荷、更低疾病活动度。
研究设计与样本
- 多伦多大学狼疮诊所观察性队列研究,纳入1970年7月至2024年8月共2264例SLE患者。
- 关节炎临床定义为非变形性关节炎(NDA)、Jaccoud关节病(JA)和临床不可复位畸形关节炎(CIDA)。
- 采用单变量和多变量逻辑回归分析,以NDA为参照,在总体队列和475例有IFN评分(高/低)亚组中评估关联。
主要发现
- 2264例中1248例(55.1%)有关节炎:908例(72.8%)NDA,239例(19.2%)JA,101例(8.1%)CIDA。
- 多变量分析中,JA与更长病程(OR 1.05 [95%CI: 1.03, 1.08])和女性(OR 2.06 [95%CI: 1.11, 3.83])相关。
- CIDA与神经受累(OR 1.79 [95%CI: 1.13, 2.84])、抗Ro抗体(OR 1.71 [95%CI: 1.01, 2.90])、更高调整平均关节计数(OR 1.09 [95%CI: 1.03, 1.77])和更低调整平均SLEDAI-2K(OR 0.89 [95%CI: 0.81, 0.98])相关。
- 475例有IFN评分患者中,CIDA在未调整分析中与低IFN特征相关,JA和NDA与高IFN特征相关。
关键数值与推荐
- 关节炎亚型定义:NDA为非变形性关节炎,JA为Jaccoud关节病,CIDA为临床不可复位畸形关节炎。
- IFN评分按高/低二分报告,具体阈值原文未报告。
临床怎么用
- 临床识别SLE关节炎亚型(NDA、JA、CIDA)有助于判断不同临床和血清学关联。
- JA患者病程更长且女性多见,CIDA患者需关注神经受累、抗Ro抗体和更高关节负荷。
- I型干扰素特征在NDA和JA中较高、在CIDA中较低,提示不同亚型可能对应不同机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Arthritis is a common manifestation of systemic lupus erythematosus (SLE). We examined the prevalence and associations of arthritis subtypes in SLE, focusing on associations with type I interferon (IFN) scores. METHODS: In this observational cohort study at the University of Toronto Lupus Clinic (July 1970-August 2024), arthritis was defined clinically as non-deforming arthritis (NDA), Jaccoud's arthropathy (JA) and arthritis with clinically irreducible deformities (CIDA). Univariable and multivariable (MV) logistic regression was used to assess associations with arthritis subtypes with NDA as reference in the prevalent cohort and subgroup with available IFN scores (reported as high/low). RESULTS: Among 2264 patients, 1248 (55.1%) had arthritis: 908 (72.8%) had NDA, 239 (19.2%) JA, and 101 (8.1%) CIDA. In the multivariable logistic regression analysis, JA was associated with longer disease duration (odds ratio [OR] 1.05 [95% CI: 1.03, 1.08]) and female sex (2.06 [1.11, 3.83]) whereas CIDA was associated with neurological involvement (1.79 [1.13, 2.84]), anti-Ro antibodies (1.71 [1.01, 2.90]), higher adjusted mean joint count (1.09 [1.03, 1.77]) and lower adjusted mean SLEDAI-2K over follow-up (0.89 [0.81, 0.98]) compared with NDA. In patients with available IFN scores (n = 475), CIDA was associated with a low IFN signature in unadjusted analysis, whereas both JA and NDA had a high IFN signature. CONCLUSION: Distinct clinical and serological patterns differentiate JA and CIDA, suggesting unique underlying mechanisms of deforming arthritis in SLE. Both NDA and JA exhibited a high IFN signature, while CIDA showed a higher joint burden, lower disease activity and lower IFN signature relative to NDA.
引用
- Mehta P, Kharouf F, Carrizo-Abarza V, et al. Characterizing arthritis subtypes in lupus: prevalence, clinical features and role of type I interferon signatures. Rheumatology (Oxford). 2026. PMID: 42484290. doi:10.1093/rheumatology/keag379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。